Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 3 | 2025 | 1085 | 0.930 |
Why?
|
| Thrombosis | 4 | 2023 | 528 | 0.900 |
Why?
|
| Methylprednisolone | 1 | 2025 | 98 | 0.890 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 305 | 0.760 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 185 | 0.720 |
Why?
|
| Thrombophilia | 1 | 2021 | 41 | 0.700 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2019 | 49 | 0.690 |
Why?
|
| Blood Coagulation | 1 | 2021 | 129 | 0.680 |
Why?
|
| Balloon Valvuloplasty | 1 | 2020 | 24 | 0.650 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 198 | 0.640 |
Why?
|
| Carotid Artery Injuries | 1 | 2018 | 37 | 0.560 |
Why?
|
| Inflammation | 1 | 2025 | 1521 | 0.530 |
Why?
|
| Head and Neck Neoplasms | 2 | 2013 | 615 | 0.530 |
Why?
|
| Aneurysm, False | 1 | 2018 | 93 | 0.510 |
Why?
|
| Tetralogy of Fallot | 1 | 2018 | 171 | 0.500 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 547 | 0.490 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 378 | 0.470 |
Why?
|
| Heart Ventricles | 1 | 2019 | 784 | 0.450 |
Why?
|
| Tranexamic Acid | 2 | 2025 | 33 | 0.430 |
Why?
|
| Antifibrinolytic Agents | 2 | 2025 | 49 | 0.420 |
Why?
|
| Laryngeal Muscles | 1 | 2013 | 6 | 0.410 |
Why?
|
| Spasm | 1 | 2013 | 48 | 0.400 |
Why?
|
| Dysphonia | 1 | 2013 | 17 | 0.400 |
Why?
|
| Cultural Diversity | 1 | 2013 | 71 | 0.400 |
Why?
|
| Heart Transplantation | 1 | 2019 | 875 | 0.390 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2025 | 659 | 0.380 |
Why?
|
| Lymphangioma | 1 | 2012 | 24 | 0.380 |
Why?
|
| Sclerotherapy | 1 | 2012 | 39 | 0.370 |
Why?
|
| Lymphatic Abnormalities | 1 | 2012 | 36 | 0.370 |
Why?
|
| Doxycycline | 1 | 2012 | 121 | 0.360 |
Why?
|
| Lung Diseases | 2 | 2025 | 408 | 0.330 |
Why?
|
| Anticoagulants | 4 | 2023 | 609 | 0.320 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17345 | 0.310 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 385 | 0.300 |
Why?
|
| Hemorrhage | 4 | 2025 | 517 | 0.290 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 550 | 0.280 |
Why?
|
| Survival Rate | 1 | 2013 | 2183 | 0.280 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1867 | 0.280 |
Why?
|
| Infant | 6 | 2025 | 13032 | 0.250 |
Why?
|
| Child | 11 | 2025 | 25756 | 0.240 |
Why?
|
| Warfarin | 2 | 2023 | 128 | 0.200 |
Why?
|
| Child, Preschool | 5 | 2025 | 14715 | 0.200 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 110 | 0.190 |
Why?
|
| Male | 9 | 2025 | 64846 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 463 | 0.190 |
Why?
|
| Adolescent | 5 | 2025 | 20524 | 0.180 |
Why?
|
| Humans | 16 | 2025 | 131930 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2025 | 12996 | 0.180 |
Why?
|
| Female | 10 | 2025 | 70607 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2021 | 63 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 220 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2021 | 333 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2021 | 323 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 511 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2022 | 8535 | 0.140 |
Why?
|
| Device Removal | 1 | 2019 | 225 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 115 | 0.140 |
Why?
|
| Angiography | 1 | 2018 | 209 | 0.140 |
Why?
|
| Echocardiography | 2 | 2020 | 1125 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 375 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 461 | 0.120 |
Why?
|
| Graft Rejection | 1 | 2019 | 558 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2019 | 864 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 1175 | 0.110 |
Why?
|
| Voice Quality | 1 | 2013 | 21 | 0.100 |
Why?
|
| Speech | 1 | 2013 | 78 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2023 | 3129 | 0.100 |
Why?
|
| Heparin | 2 | 2022 | 212 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2023 | 1350 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 9929 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 1604 | 0.070 |
Why?
|
| Adult | 2 | 2019 | 31506 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2025 | 190 | 0.050 |
Why?
|
| Factor IX | 1 | 2023 | 15 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2163 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2023 | 24 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5394 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2023 | 35 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 36 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 247 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 65 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 130 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2022 | 157 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7545 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 551 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 119 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 797 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 2920 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6435 | 0.020 |
Why?
|